CANF

Can-Fite BioPharma

5 hedge funds and large institutions have $1.59M invested in Can-Fite BioPharma in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 5 closing their positions.

Holders
5
Holders Change
-2
Holders Change %
-28.57%
% of All Funds
0.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
Reduced
1
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
TAM
1
Taylor Asset Management
Ontario, Canada
$1.53M 796,500
SM
2
Sabby Management
Florida
$57K 30,017 +30,017 New
PVH
3
Psagot Value Holdings
Israel
$6K 3,209 +3,209 New
Morgan Stanley
4
Morgan Stanley
New York
$1K 500 -2,100 -81%
Simplex Trading
5
Simplex Trading
Illinois
$1K 1,000 +1,000 New
MC
6
Menta Capital
California
-41,837 Closed
Citadel Advisors
7
Citadel Advisors
Florida
-14,292 Closed
VKH
8
Virtu KCG Holdings
New York
-12,076 Closed
UBS Group
9
UBS Group
Switzerland
-2,425 Closed
LTFS
10
Ladenburg Thalmann Financial Services
Florida
-200 Closed